https://clinicaltrials.gov/ct2/show/NCT04095793?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=09%2F05%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Extension Study of Ampreloxetine (TD-9855) for Treating snOH in Subjects With Primary Autonomic Failure
DESCRIPTION:
Condition: Symptomatic Neurogenic Orthostatic Hypotension
Intervention: Drug: ampreloxetine
Sponsor: Theravance Biopharma
Not yet recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT04095793
FIRST POSTED:
Thu, 19 Sep 2019 12:00:00 EDT
LAST UPDATE POSTED:
09/19/19 08:06AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT04095793?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=09%2F05%2F2019&lupd_d=14&sort=nwst